A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.

Cancer Immunol Immunother · 2023 · PMC10264280 · PMID 36881133

Europe PMC DOI

hedged sentence

0.5500

closest p · 11.0× alpha

0.5500

boldest claim

The sentences

did not reach statistical significanceP = 0.55not close (p > 0.1)

In assessment of mean T cell count by ex vivo IFN-γ ELISpot, the additional impact of vaccine treatment on AUC did not reach statistical significance (Fig. 4 ) (7.60, 95% confidence interval − 16.18 to 30.31; P = 0.55).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.